Zheng Zhang to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Zheng Zhang has written about Adrenergic beta-Antagonists.
Connection Strength
0.129
-
Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial. Pacing Clin Electrophysiol. 2017 Jul; 40(7):770-778.
Score: 0.129